{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T10:36:45Z","timestamp":1794998205721,"version":"4.9.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.eururo.2024.04.031","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:32:35Z","timestamp":1715704355000},"page":"315-326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review"],"prefix":"10.1016","volume":"86","author":[{"given":"Massimiliano","family":"Creta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio I.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Bhojani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus J.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Peyronnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Roehrborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari A.O.","family":"Tikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Nicolas","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2024.04.031_b0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.eururo.2023.02.028","article-title":"Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis","volume":"83","author":"Cornu","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0010","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/nau.23554","volume":"37","author":"Fusco","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2024.04.031_b0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12894-018-0329-4","article-title":"Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans","volume":"18","author":"Fusco","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","article-title":"Summary paper on the 2023 European Association of Urology guidelines on the management of non-neurogenic male lower urinary tract symptoms","volume":"84","author":"Gravas","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0025","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2024.04.031_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1472-6947-7-16","article-title":"Utilization of the PICO framework to improve searching PubMed for clinical questions","volume":"7","author":"Schardt","year":"2007","journal-title":"BMC Med Inf Decis Mak"},{"key":"10.1016\/j.eururo.2024.04.031_b0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2024.04.031_b0040","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2024.04.031_b0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2017.08.016","article-title":"EAU Guidelines Office Senior Associates Group Authorship. Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology","volume":"73","author":"Knoll","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00005392-200101000-00010","article-title":"Alpha-blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it","volume":"165","author":"Rossi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11255-012-0317-7","article-title":"Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial","volume":"45","author":"Regadas","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.eururo.2024.04.031_b0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1464-410x.2001.00983.x","article-title":"Tamsulosin in men with confirmed bladder outlet obstruction: a clinical and urodynamic analysis from a single centre in New Zealand","volume":"87","author":"Arnold","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2024.04.031_b0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1464-410X.2006.06030.x","article-title":"Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study","volume":"97","author":"Nishino","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2024.04.031_b0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/nau.20802","article-title":"Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia","volume":"29","author":"Yamanishi","year":"2010","journal-title":"Neurourol Urodyn"},{"issue":"1 Suppl","key":"10.1016\/j.eururo.2024.04.031_b0075","first-page":"S117","article-title":"Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study","volume":"189","author":"Matsukawa","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12894-018-0326-7","article-title":"Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study","volume":"18","author":"Fusco","year":"2018","journal-title":"BMC Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0085","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/iju.13333","article-title":"Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms","volume":"24","author":"Matsukawa","year":"2017","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000071090","article-title":"Clinical and pressure-flow changes after long-term treatment with alfuzosin SR","volume":"71","author":"De Nunzio","year":"2003","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2024.04.031_b0095","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0022-5347(05)65012-4","article-title":"Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia","volume":"167","author":"Tanaka","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1442-2042.2004.00844.x","article-title":"Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (Eviprostat) in the treatment of benign prostatic hyperplasia","volume":"11","author":"Yamanishi","year":"2004","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/iju.12438","article-title":"Effects of dutasteride on storage and voiding symptoms in male patients with lower urinary tract symptoms as a result of benign prostatic obstruction: the 1-year outcomes from a prospective urodynamic study","volume":"21","author":"Matsukawa","year":"2014","journal-title":"Int J Urol"},{"issue":"1 Suppl","key":"10.1016\/j.eururo.2024.04.031_b0110","first-page":"S135","article-title":"Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial","volume":"189","author":"Dmochowski","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0115","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.juro.2017.05.031","article-title":"Effects of withdrawing \u03b11-blocker from combination therapy with \u03b11-blocker and 5\u03b1-reductase inhibitor in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a prospective and comparative trial using urodynamics","volume":"198","author":"Matsukawa","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.eururo.2006.04.002","article-title":"A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years","volume":"50","author":"Wilson","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0125","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/01.ju.0000176740.76061.24","article-title":"The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction","volume":"174","author":"Thomas","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0130","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.urology.2005.12.036","article-title":"Urodynamics after TURP and HoLEP in urodynamically obstructed patients: are there any differences at 1 year of follow-up?","volume":"67","author":"Rigatti","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2024.04.031_b0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.urology.2019.01.020","article-title":"Urodynamic outcomes after aquablation","volume":"126","author":"Pimentel","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2024.04.031_b0140","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1464-410X.2011.10878.x","article-title":"GreenLight HPS\u2122 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation","volume":"110","author":"Pereira-Correia","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2024.04.031_b0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5534\/wjmh.2012.30.3.160","article-title":"Can 80 W KTP laser vaporization effectively relieve the obstruction in benign prostatic hyperplasia?: A nonrandomized trial","volume":"30","author":"Han","year":"2012","journal-title":"World J Mens Health"},{"key":"10.1016\/j.eururo.2024.04.031_b0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.urology.2013.10.037","article-title":"Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study","volume":"83","author":"Kwon","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2024.04.031_b0155","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.ju.0000161610.68204.ee","article-title":"Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 grams: a randomized trial","volume":"174","author":"Aho","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0160","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3109\/21681805.2012.759272","article-title":"Urodynamic effect of 80 watt photoselective laser vaporization of the prostate","volume":"47","author":"Wille","year":"2013","journal-title":"Scand J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0165","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.eururo.2008.05.003","article-title":"Functional outcome following photoselective vaporisation of the prostate (PVP): urodynamic findings within 12 months follow-up","volume":"54","author":"Hamann","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0170","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/JU.0000000000000685","article-title":"Ejaculatory hood sparing versus standard laser photoselective vaporization of the prostate: sexual and urodynamic assessment through a double blinded, randomized trial","volume":"203","author":"Abolazm","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0175","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/bju.13358","article-title":"Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience","volume":"117","author":"Gilling","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2024.04.031_b0180","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1089\/end.2021.0050","article-title":"Urodynamic effects of prostaticurethral lift procedure for male voiding lower urinary tract symptoms","volume":"35","author":"Muller","year":"2021","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2024.04.031_b0185","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s00270-013-0611-5","article-title":"Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study","volume":"36","author":"Antunes","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.eururo.2024.04.031_b0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/nau.25076","article-title":"Transurethral water vapor ablation of the prostate with the Rez\u016bm system: Urodynamic findings","volume":"42","author":"Martinelli","year":"2023","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2024.04.031_b0195","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","article-title":"Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?","volume":"154","author":"Barry","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2015.12.048","article-title":"Latest evidence on the use of phosphodiesterase type 5 inhibitors for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"70","author":"Gacci","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0205","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.eururo.2015.12.034","article-title":"\u03b11-Blockers improve benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review and meta-analysis of urodynamic studies","volume":"69","author":"Fusco","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0210","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12325-017-0504-0","article-title":"Benign prostatic obstruction relief in patients with lower urinary tract symptoms suggestive of benign prostatic enlargement undergoing endoscopic surgical procedures or therapy with alpha-blockers: a review of urodynamic studies","volume":"34","author":"Fusco","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.eururo.2024.04.031_b0215","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.eururo.2011.08.055","article-title":"Benign prostatic hyperplasia and lower urinary tract symptoms: research priorities","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ucl.2016.04.009","article-title":"Alpha-blockers for the treatment of benign prostatic hyperplasia","volume":"43","author":"Lepor","year":"2016","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.eururo.2024.04.031_b0225","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11918-996-0012-1","article-title":"Mode of action of \u03b1-adrenoceptor antagonists in the treatment of lower urinary tract symptoms","volume":"3","author":"Andersson","year":"2005","journal-title":"Curr Prostate Rep"},{"key":"10.1016\/j.eururo.2024.04.031_b0230","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2012.09.006","article-title":"The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"63","author":"Giuliano","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0235","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.eururo.2020.06.004","article-title":"Diagnostic assessment of lower urinary tract symptoms in men considering prostate surgery: a noninferiority randomised controlled trial of urodynamics in 26 hospitals","volume":"78","author":"Drake","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0240","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.euf.2023.06.013","article-title":"Predicting prostate surgery outcomes from standard clinical assessments of lower urinary tract symptoms to derive prognostic symptom and flowmetry criteria","volume":"10","author":"Ito","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2024.04.031_b0245","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2020.12.019","article-title":"A systematic review of patients' values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms","volume":"79","author":"Malde","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1520-6777(1998)17:2<99::AID-NAU3>3.0.CO;2-7","article-title":"Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-\u201cBPH\u201d study","volume":"17","author":"de la Rosette","year":"1998","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2024.04.031_b0255","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/JU.0000000000001149","article-title":"Grading severity and bother using the international prostate symptom score and international consultation on incontinence questionnaire male lower urinary tract symptoms score in men seeking lower urinary tract symptoms therapy","volume":"204","author":"Ito","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2024.04.031_b0260","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/nau.23124","article-title":"International Continence Society good urodynamic practices and terms 2016: urodynamics, uroflowmetry, cystometry, and pressure-flow study","volume":"36","author":"Rosier","year":"2017","journal-title":"Neurourol Urodyn"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283824023595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283824023595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T22:40:22Z","timestamp":1726785622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283824023595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0302283824023595"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2024.04.031","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2024.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}